YolTech raises $70.0M (China, May 2026)
$70.0M
$70MGenerated social card
Headline
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward - Endpoints News
About
YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.
Article summary
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward Endpoints News
Founder
Yuxuan Wu
CEO
Investors
Related rounds
| Aug 14, 2026 | INFIFORCE | $136.0M | Series A | China |
| Aug 09, 2026 | StairMed | $163.0M | — | China |
| Aug 09, 2026 | Xiangdixian Computing Technology | $200.0M | Series B | China |
| Jul 27, 2026 | Photon Matrix Lab | $2.7M | — | China |